We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Brivaracetam

News List

Zydus Cadila gets tentative US FDA approval for Brivaracetam tablets expresspharma
June 16, 2021
Zydus Cadila has received tentative approval from the USFDA to market Brivaracetam Tablets, in the strengths of 10 mg, 25 mg, 50 mg, 75 mg, and 100 mg (US RLD: Briviact Tablets). Brivaracetam is used to treat partial-onset of seizures (epilepsy).
Alkem launches anti-epileptic drug BRIVASURE (Brivaracetam) expresspharma
March 16, 2021
Alkem Laboratories announced the launch of Brivasure, an affordable anti-epileptic drug for the treatment of epilepsy in India.
NATCO launches Brivaracetam tablets in India expresspharma
March 01, 2021
Natco Pharma announced the launch of Brivaracetam tablets under brand BRECITA in India.
Sun Pharma to launch entire range of Brivaracetam for epilepsy treatment in India expresspharma
February 24, 2021
Brivaracetam is an anti-epileptic drug (AEDs) with fast onset of action and promising efficacy.